Copyright
©The Author(s) 2021.
World J Clin Cases. Dec 6, 2021; 9(34): 10494-10506
Published online Dec 6, 2021. doi: 10.12998/wjcc.v9.i34.10494
Published online Dec 6, 2021. doi: 10.12998/wjcc.v9.i34.10494
Variable | Segmentectomy (n = 57) | Lobectomy(n = 66) | Total (n = 123) |
Age, mean (range), yr | 59.3 ± 10.8 (39.0-75.0) | 63.2 ± 8.5 (44.0-80.0) | 61.4 ± 9.8 (39.0-80.0) |
Gender | |||
Female | 31 (54.4%) | 28 (42.4%) | 59 (48.0%) |
Male | 26 (45.6%) | 38 (57.6%) | 64 (52.0%) |
Smoking history | 19 (33.3%) | 31 (47.0%) | 50 (40.7%) |
Comorbidity | |||
Hypertension | 14 (24.6%) | 11 (16.7%) | 25 (20.3%) |
Diabetes mellitus | 6 (10.5%) | 4 (6.1%) | 10 (8.1%) |
COPD | 5 (8.8%) | 7 (10.6%) | 12 (9.8%) |
Arrhythmia | 1 (1.8%) | 2 (3.0%) | 3 (2.4%) |
Operative time, mean (range), min | 129.8 ± 16.1 (105-180) | 125.2 ± 11.7 (105-160) | 113.4 ± 19.7 (20-150) |
Blood loss, mean (range), mL | 48.8 ± 26.2 (20-150) | 79.5 ± 34.0 (20-220) | 65.3 ± 34.2 (20-220) |
Duration of chest tube placement, mean (range), d | 3.1 ± 1.1 (2.0-9.0) | 3.8 ± 1.9 (2.0-10.0) | 3.5 ± 1.6 (2.0-10.0) |
Postoperative hospital stay, mean (range), d | 6.4 ± 1.3 (5.0-12.0) | 7.1 ± 2.2 (5.0-15.0) | 6.8 ± 1.8 (5.0-15.0) |
Tumor diameter, mean (range), mm | 10.5 ± 4.9 (5.0-25.0) | 23.4 ± 12.1 (8.0-60.0) | 17.4 ± 11.4 (5.0-60.0) |
Appearance on CT | |||
Pure GGO | 12 (21.1%) | 1 (1.5%) | 13 (10.6) |
p GGO | 45 (78.9%) | 23 (34.8%) | 68 (55.3%) |
Solid | 0 (0%) | 42 (63.6%) | 42 (34.1%) |
Histological types | |||
Adenocarcinoma | 56 (98.2%) | 56 (84.8%) | 112 (91.1%) |
AIS | 8 (14.0%) | 3 (4.5%) | 11 (8.9%) |
MIA | 20 (35.1%) | 1 (1.5%) | 21 (17.1%) |
IA | 28 (49.1%) | 52 (78.8%) | 80 (65.0%) |
Squamous cell | 1 (1.8%) | 7 (10.6%) | 8 (6.5%) |
Others | 0 (0%) | 3 (4.5%) | 3 (2.4%) |
Postoperative complications | 2 (3.5%) | 8 (12.1%) | 10 (8.1%) |
Pneumonia | 0 (0%) | 1 (1.5%) | 1 (0.8%) |
Prolonged air leakage (> 5 d) | 2 (3.5%) | 1 (1.5%) | 3 (2.4%) |
Chylothorax | 0 (0%) | 6 (9.1%) | 6 (4.9%%) |
Absent | 55 (96.5%) | 58 (87.9%) | 113 (91.9%) |
Conversion rate | 0 (0%) | 0 (0%) | 0 (0%) |
30-d mortality | 0 (0%) | 0 (0%) | 0 (0%) |
Postoperative ICU stay | 0 (0%) | 0 (0%) | 0 (0%) |
- Citation: Wu YJ, Shi QT, Zhang Y, Wang YL. Thoracoscopic segmentectomy and lobectomy assisted by three-dimensional computed-tomography bronchography and angiography for the treatment of primary lung cancer. World J Clin Cases 2021; 9(34): 10494-10506
- URL: https://www.wjgnet.com/2307-8960/full/v9/i34/10494.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i34.10494